120 (OR = 3.3, CI = 1.14-9.7), Cross Clamp time>80 min (OR = 4.16, CI = 1.73-9.98) and IABP insertion postoperatively (OR = 19.19, CI = 3.16-116.47). The incremental risk factors for the development of complications were: Poor EF (OR = 3.16, CI = 0.87-11.52), Euroscore >7 (OR = 2.99, CI = 1.14-7.88), history of PVD (OR = 4.99, CI = 1.32-18.86). The 5 years survival was 79.2% for the CABG population and 71.5% for the valve group. (Hazard ratio = 1.78, CI = 0.92-3.46). Conclusions IABP represents a safe option of supporting the failing heart. The need for IABP especially in a high risk Valve population is associated with early unfavourable outcome, however the positive mid term results further justify its use."/>
Procedures | Number | Percent | Mortality |
---|---|---|---|
CABG only | 80 | 58.8 | 16 (21.2%) |
CABG + Valve | 22 | 16.2 | 11 (50%) |
CABG + Other | 11 | 8.1 | 6 (54.5%) |
CABG & VSD (6) | 3 | ||
CABG & Lung Biopsy (1) | 1 | ||
CABG & Aortotomy & Exploration LV (1) | 1 | ||
CABG & LV Aneurysectomy (1) | 0 | ||
CABG & Root Replacement (1) | 0 | ||
CABG & SVG Aneurysm (1) | 1 | ||
Valve Only | 14 | 10.3 | 9 (64.3%) |
Valve + Other | 2 | 1.5 | 0 |
Other | 7 | 5.1 | 6 (85.3%) |
136 | entries | 48 patients |